Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3)

Naoko Hashimoto Takigami, Shimpei Kuniyoshi, Yasuhiro Miki, Kentaro Tamaki, Yoshihiko Kamada, Kano Uehara, Seiko Tsuchiya, Shigeharu Terukina, Erina Iwabuchi, Ayako Kanai, Minoru Miyashita, Takanori Ishida, Nobumitsu Tamaki, Hironobu Sasano

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original publication of the article, the antibody against GLP-1R which we used in this study was not mouse monoclonaly ab166987 as reported in the manuscript but rabbit polyclonal ab188602, both commercially obtained from Abcam.

Original languageEnglish
JournalBreast Cancer Research and Treatment
DOIs
Publication statusAccepted/In press - 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations (Breast Cancer Research and Treatment, (2021), 189, 1, (39-48), 10.1007/s10549-021-06288-3)'. Together they form a unique fingerprint.

Cite this